Log in to save to my catalogue

Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross‐sectional study

Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross‐sectional study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11555154

Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross‐sectional study

About this item

Full title

Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross‐sectional study

Publisher

England: John Wiley & Sons, Inc

Journal title

European journal of neurology, 2024-12, Vol.31 (12), p.e16476

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Data on health-related quality of life (HRQoL) and mood in cerebral amyloid angiopathy (CAA), a disease characterized by stroke and cognitive decline, are limited. We aimed to investigate the impacted domains of life, value-based HRQoL and the prevalence of depression and anxiety in patients with CAA.
We conducted a cross-sectional study of pati...

Alternative Titles

Full title

Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross‐sectional study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11555154

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11555154

Other Identifiers

ISSN

1351-5101,1468-1331

E-ISSN

1468-1331

DOI

10.1111/ene.16476

How to access this item